Hereditary pathogenetic mutations in known breast cancer susceptibility genes (e.g., BRCA1) only explain a small percentage (5–10%) of breast cancer cases in the general population [2]; thus, identifying genetic variants and their associated gene networks that contribute to breast cancer risk remains paramount. This evidence concerns the gene BRCA1 and breast carcinoma.